Medical/Pharmaceuticals
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™
SHANGHAI, Jan. 16, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that a patent for WuXiBodyTM – a proprietary, highly flexible engineering platform that greatly enhances the deve...
2024-01-17 08:30
4139
SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)
The Cost of Sepsis in Australia report (2021) estimated that there are >90,000 sepsis cases inAustralia each year and estimated direct and indirect costs of $700 million and $4 billion respectively SEATTLE and BRISBANE, Australia, Jan. 17, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular...
2024-01-17 06:00
1923
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening
* Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung's premium X-ray devices SEOUL, South Korea, Jan. 16, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and t...
2024-01-16 22:04
2078
Complete Genomics and Gencove Announce agreement at Plant and Animal Genome Conference (PAG 31) to offer a bundled solution for low-pass whole genome sequencing
SAN JOSE, Calif., Jan. 16, 2024 /PRNewswire/ -- Complete Genomics
2024-01-16 22:00
1699
FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY
This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this...
2024-01-16 21:00
1576
Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule
CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule ...
2024-01-16 21:00
1956
HOPE FOR FEMALE CANCER PATIENTS TO PRESERVE FERTILITY THROUGH OVARIAN TISSUE CRYOPRESERVATION AT SUNFERT
Sunfert International Fertility Centre is the First Private Oncofertility Hub in Malaysia KUALA LUMPUR, Malaysia, Jan. 16, 2024 /PRNewswire/ -- Reproductive medicine has achieved groundbreaking milestones, andMalaysia is one of the countries that is sought after by couples near and far to realis...
2024-01-16 18:14
1736
Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors
CHENGDU, China, Jan. 16, 2024 /PRNewswire/ -- Chengdu Chipscreen NewWay Biosciences Co., Ltd. (NewWay) announced that onJanuary 5, 2024, the dosing of the first patient for a phase I clinical trial of a PD-1/CD40 bispecific antibody (bsAb), NWY001, at Sun Yat-Sen University Cancer Center inChina,...
2024-01-16 17:00
2070
TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision in a Growth-Buy Out Transaction
Alina Vision operates hospitals in the underserved Vietnamese ophthalmology market, providing affordable and high-quality eye care services for people across all income levels to combat avoidable blindness; and meeting the impact investing strategy of TVM Capital Healthcare SINGAPORE and HANOI, ...
2024-01-16 16:55
2158
International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries
The partnership will enhance diabetes care through training aimed at building
capacity among healthcare professionals in low and middle-income countries.
BRUSSELS, Jan. 16, 2024 /PRNewswire/ -- The International Diabetes Federation
(IDF)
2024-01-16 15:00
1507
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO)demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients with hormone receptor (HR) positive)/human epidermal growth factor receptor (HER) 2 negative metast...
2024-01-16 15:00
1674
Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac
HSINCHU, Jan. 16, 2024 /PRNewswire/ -- Brain Navi announced the completion of
the 100th case utilizing its neurosurgical navigation robot NaoTrac. The 100th
case has been performed by Neurosurgery Department Director Dr. Hao-Yu Chuang
at Annan Hospital in Tainan,Taiwan.
2024-01-16 11:03
3505
PranaQ to Unveil Revolutionary Sleep Tech at CES 2024: Introducing TipTraQ, the AI Sleep Tracking and Improvement Solution
NEW YORK, Jan. 15, 2024 /PRNewswire/ -- PranaQ, the innovative sleep tech startup, has made waves at CES 2024 with the highly anticipated launch of its flagship product, TipTraQ. This cutting-edge device goes beyond traditional sleep monitoring, offering a comprehensive solution for diagnosing an...
2024-01-16 00:00
1748
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection
SHANGHAI, Jan. 15, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that CT011, an autologous CAR T-cell product candidate against Glypic...
2024-01-15 21:50
1950
The Human Change campaign launched at World Economic Forum in Davos to make children's mental health a global priority
'Human change' is happening now, caused by the over-digitalization of
children's lives –the world must prioritize the alignment of technological
progress with the healthy development of children.
DAVOS, Switzerland, Jan. 15, 2024 /PRNewswire/ -- Global advocacy campaign,
Human Change
2024-01-15 15:00
2208
NX China Takes Part in 9th Annual Medical Device Supply Chain Conference
TOKYO, Jan. 15, 2024 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., participated in the three-day 9th Annual Medical Device Supply Chain Conference held inChengdu, China, from November 25 to 27, 2023. Logo: https://kyo...
2024-01-15 14:00
1902
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care inIndia BOSTON and ROLLE, Switzerland, Jan. 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (N...
2024-01-15 12:00
1903
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia
SHANGHAI, Jan. 14, 2024 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical-stage innovative biopharmaceutical company, announced recently that the company has completed a Phase Ib study, "An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgene...
2024-01-15 08:08
1786
San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus toSan Francisco. The J.P. Morgan Healthcare Conference has been successfully held here for 42 editions, becoming a hall where industry thought converges and spar...
2024-01-12 23:28
6464
Subject Enrollment Completed for International Multicenter Comparative Clinical (Phase 3) Study of Boan Biotech's Denosumab
A meeting was also held in Germany to announce the results of the international pharmacokinetic similarity clinical (Phase 1) study BERLIN, Jan. 12, 2024 /PRNewswire/ -- Boan Biotech recently announced that subject enrollment for the international multicenter comparative clinical (Phase 3) study...
2024-01-12 21:15
2964
Week's Top Stories
Most Reposted
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 313 media titles]
2025-01-22 15:38
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 309 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Blackpanda Recognized with Frost & Sullivan's Asia Pacific Company of the Year Award for Incident Response Excellence
[Picked up by 300 media titles]
2025-01-23 09:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 291 media titles]
2025-01-20 21:09
Most Read
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
2025-01-21 16:00
7062
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
2025-01-20 14:27
4924
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
2025-01-22 15:38
4899